Table of contents

November 2004 Volume 1 No 1

Top

Editorial

Why a new journal?

Peter T Scardino

1

doi:10.1038/ncpuro0030 | Full Text | PDF (75K)

Top

Viewpoints

Treatment of chronic prostatitis

Richard B Alexander

2

doi:10.1038/ncpuro0003 | Full Text | PDF (89K)

Early cystectomy for clinical stage T1 bladder cancer

Brent K Hollenbeck and James E Montie

4

doi:10.1038/ncpuro0008 | Full Text | PDF (92K)

Top

Research Highlights

Benefits of exercise in radiotherapy

6

doi:10.1038/ncpuro0015 | Full Text | PDF (106K)

Prevention of postoperative erections: role for ketoconazole?

6

doi:10.1038/ncpuro0016 | Full Text | PDF (106K)

Magnetic stimulation for urinary incontinence

6

doi:10.1038/ncpuro0017 | Full Text | PDF (118K)

VUR resolved by bladder augmentation without antireflux surgery

7

doi:10.1038/ncpuro0018 | Full Text | PDF (106K)

Evidence Based Medicine

Plant-derived medication for LUTS

7

doi:10.1038/ncpuro0019 | Full Text | PDF (106K)

Predicting clinical outcome in prostate cancer

8

doi:10.1038/ncpuro0020 | Full Text | PDF (112K)

Reducing rectal toxicity in 3D-CRT

8

doi:10.1038/ncpuro0025 | Full Text | PDF (112K)

Improving continence following radical prostatectomy

8

doi:10.1038/ncpuro0026 | Full Text | PDF (123K)

Subjective assessment of female urinary incontinence

9

doi:10.1038/ncpuro0027 | Full Text | PDF (104K)

Urinary tract infections in spinal cord injury outpatients

9

doi:10.1038/ncpuro0031 | Full Text | PDF (120K)

Bone complications in prostate cancer

10

doi:10.1038/ncponc0004 | Full Text | PDF (119K)

Survival benefit with 6-month androgen suppression and 3D-CRT

10

doi:10.1038/ncpuro0032 | Full Text | PDF (109K)

Urine dipstick testing for hematuria

10

doi:10.1038/ncpuro0033 | Full Text | PDF (109K)

The blood–testis barrier in health and disease

11

doi:10.1038/ncponc0018 | Full Text | PDF (108K)

Top

Practice Points

Should men with serum PSA levels of 4.0 ng/ml or less undergo a prostate biopsy?

J Brantley Thrasher

12

doi:10.1038/ncpuro0013 | Full Text | PDF (108K)

Do 5ARIs or alpha blockers more effectively reduce the risk of BPH-related acute urinary retention and surgery?

Christopher R Chapple

14

doi:10.1038/ncpuro0023 | Full Text | PDF (87K)

Does the midstream urine culture and sensitivity test reliably predict infected urine near a ureteral obstruction?

Margaret S Pearle

16

doi:10.1038/ncpuro0004 | Full Text | PDF (90K)

Does the effectiveness of bicalutamide in reducing the risk of prostate cancer progression vary with lymph node status?

Peter Albertsen

18

doi:10.1038/ncpuro0002 | Full Text | PDF (87K)

Does the one- or two-stage implantation technique for sacral neuromodulation more effectively relieve LUTS?

Klaus-Peter Jünemann

20

doi:10.1038/ncpuro0010 | Full Text | PDF (92K)

Is trospium chloride an effective and safe treatment for overactive bladder syndrome?

Christopher K Payne

22

doi:10.1038/ncpuro0011 | Full Text | PDF (92K)

Is transurethral needle ablation a safe and effective treatment for lower urinary tract symptoms secondary to BPH?

Laurent Boccon Gibod

24

doi:10.1038/ncpuro0006 | Full Text | PDF (95K)

Top

Reviews

Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy

Paul Russo

26

doi:10.1038/ncpuro0029 | Full Text | PDF (169K)

Evidence Based Medicine

Botulinum toxin in urology: evaluation using an evidence-based medicine approach

Christopher P Smith, George T Somogyi and Timothy B Boone

31

doi:10.1038/ncpuro0034 | Full Text | PDF (234K)

Current views on evaluation, management, and gender assignment of the intersex infant

Caleb P Nelson and John P Gearhart

38

doi:10.1038/ncpuro0028 | Full Text | PDF (172K)

Technology Insight: novel ureteral stent materials and designs

Ben H Chew and John D Denstedt

44

doi:10.1038/ncpuro0014 | Full Text | PDF (160K)

Top

Case Study

Continuing Medical Education

Erectile dysfunction and priapism

Derek J Bochinski, Robert C Dean and Tom F Lue

49

doi:10.1038/ncpuro0022 | Full Text | PDF (419K)

Extra navigation

.

ADVERTISEMENT